Incorporating Risk Factors to Identify the Indication of Post-mastectomy Radiotherapy in N1 Breast Cancer Treated with Optimal Systemic Therapy: A Multicenter Analysis in Korea (KROG 14-23)

Cancer Research and Treatment - Tập 49 Số 3 - Trang 739-747 - 2017
Hae Jin Park1, Kyung Hwan Shin2, Jin Ho Kim3, Seung Do Ahn4, Ja Young Kim5, Won Park6, Yong Bae Kim7, Soo‐Hyun Kim8, Jin Hee Kim9, Kyubo Kim10, Kyung Ran Park11, Hyun Soo Shin12, Bae Kwon Jeong13, Sun Young Lee14, Suzy Kim15
1Department of Radiation Oncology, Hanyang University Hospital, Seoul, Korea
2Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea
3Department of Radiation Oncology, Seoul National University Hospital, Seoul, Korea
4Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
5Department of Radiation Oncology, Asan Medical Center, Seoul, Korea
6Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
7Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea
8Department of Radiation Oncology, Proton Therapy Center, National Cancer Center, Goyang, Korea
9Department of Radiation Oncology, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea
10Department of Radiation Oncology, Ewha Womans University School of Medicine, Seoul, Korea
11Department of Radiation Oncology, Ewha Womans University Mokdong Hospital, Seoul, Korea
12Department of Radiation Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea
13Department of Radiation Oncology, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea
14Department of Radiation Oncology, Chonbuk National University Hospital, Jeonju, Korea
15Department of Radiation Oncology, Seoul Metropolitan Government–Seoul National University Boramae Medical Center, Seoul, Korea

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1093/annonc/mdv221

10.6004/jnccn.2016.0037

10.3857/roj.2016.01753

10.1200/JCO.2001.19.5.1539

10.1016/S0140-6736(14)60488-8

10.1016/j.radonc.2007.02.001

10.1200/JCO.2010.32.3550

10.1038/35021093

10.1073/pnas.191367098

2005, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials, 1687

10.1093/annonc/mdr304

10.1245/s10434-016-5435-5

10.1016/S0140-6736(11)60993-8

10.1016/S0140-6736(11)61625-5

10.1200/JCO.2007.14.5565

10.1007/s10549-011-1891-6

10.1073/pnas.1732912100

10.1016/j.ijrobp.2015.07.006

10.1200/JCO.2009.24.9284

10.1371/journal.pone.0145463

10.1016/j.clon.2007.10.004